scholarly journals PF163 TARGETING LYSOSOMES AS A POTENTIAL THERAPEUTIC APPROACH FOR T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA

HemaSphere ◽  
2019 ◽  
Vol 3 (S1) ◽  
pp. 33-34
Author(s):  
A. Banus Mulet ◽  
J.M. Cornet-Masana ◽  
J.M. Carbó ◽  
L. Cuesta-Casanovas ◽  
F. Guijarro ◽  
...  
2012 ◽  
Vol 2012 (mar26 1) ◽  
pp. bcr0120125685-bcr0120125685
Author(s):  
V. R. Bhatt ◽  
M. Naqi ◽  
R. Bartaula ◽  
S. Murukutla ◽  
S. Misra ◽  
...  

1984 ◽  
Vol 56 (1) ◽  
pp. 139-146 ◽  
Author(s):  
Barbara A. Miller ◽  
Michael M. Reid ◽  
Marilyn Nell ◽  
Jeffrey M. Lipton ◽  
Stephen E. Sallan ◽  
...  

2007 ◽  
Vol 137 (4) ◽  
pp. 319-328 ◽  
Author(s):  
Nicholas G. Gottardo ◽  
Katrin Hoffmann ◽  
Alex H. Beesley ◽  
Joseph R. Freitas ◽  
Martin J. Firth ◽  
...  

The Lancet ◽  
1991 ◽  
Vol 338 (8777) ◽  
pp. 1277-1278 ◽  
Author(s):  
Janos Luka ◽  
SamuelJ. Pirruccello ◽  
JohnH. Kersey

2020 ◽  
Vol 13 (3) ◽  
pp. e233941
Author(s):  
Sanjeev Khera ◽  
Suman Kumar Pramanik ◽  
Suprita Kalra ◽  
Aradhana Dwivedi

Lactic acidosis (LA) is characterised by persistently increased blood lactate >5 mmol/L. Type A LA due to anaerobic glycolysis is frequently seen during management of haematological malignancies. A rare form of LA known as type B LA, which occurs as a result of metabolic dysregulation at cellular level has been described recently. This has been reported to be because of Warburg effect (WE) or aerobic glycolysis, which is seen in cancerous cells as they rely on aerobic glycolysis rather than oxidative phosphorylation for energy generation. Presence of type B LA at initial presentation of haematological malignancies is a poor prognosticating factor and has rarely been reported in children. We present a child with T cell acute lymphoblastic leukaemia with mild phenotype of type B LA due to WE. She responded dramatically to definitive chemotherapy and tolerated intensive phase of chemotherapy without any significant morbidity.


Sign in / Sign up

Export Citation Format

Share Document